Approval · Notice of Compliance 955 · 2000
GEN-ACYCLOVIR: Notice of Compliance 955
Issued July 4, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 955
- Date
- July 4, 2000
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-ACYCLOVIR | 02242463 | Marketed |
| GEN-ACYCLOVIR | 02242464 | Marketed |